List of insiders holdings for Ultragenyx Pharmaceutical Inc.:
- Shares directly owned by the insider.
- Shares indirectly owned by the insider.
- Total shares owned by the insider (sum of shares directly and indirectly owned).
- Total market value if available.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
# | Insider Holder Name | Report Date Time |
Shares Owned Directly Indirectly |
Total Shares Owned |
Filing |
1 | KAKKIS EMIL D President & CEO |
2025-03-04 20:10:16 | 720,179 2,158,985 |
2,879,164 | Form 4 |
2 | FMR LLC See Remark 1. |
2020-02-07 11:32:16 | 1,824,565 0 |
1,824,565 | Form 13G |
3 | TPG Group Holdings (SBS) Advisors Inc. BONDERMAN DAVID COULTER JAMES G Former 10% Owner (2)(3)(4)(5) |
2015-02-13 12:24:24 | 1,596,420 0 |
1,596,420 | Form 13G |
4 | Kassberg Thomas Richard CBO & EVP |
2025-03-04 20:19:57 | 264,730 0 |
264,730 | Form 4 |
5 | Aliski William Director |
2021-06-28 18:26:31 | 70,974 80,806 |
151,780 | Form 4 |
6 | Huang Dennis Karl See Remarks |
2025-03-04 20:02:17 | 140,665 0 |
140,665 | Form 4 |
7 | Pinion John Richard See Remarks |
2025-03-04 20:12:26 | 134,502 0 |
134,502 | Form 4 |
8 | Harris Erik EVP & Chief Commercial Officer |
2025-03-04 20:06:23 | 118,101 0 |
118,101 | Form 4 |
9 | Horn Howard Chief Financial Officer |
2025-03-10 12:53:00 | 106,169 0 |
106,169 | Form 4 |
10 | Crombez Eric EVP and Chief Medical Officer |
2025-03-04 20:16:48 | 102,168 0 |
102,168 | Form 4 |
11 | Sharp Shalini EVP, Finance |
2020-10-16 19:15:35 | 97,812 0 |
97,812 | Form 4 |
12 | Parschauer Karah Herdman EVP and Chief Legal Officer |
2025-03-04 20:18:24 | 75,287 0 |
75,287 | Form 4 |
13 | Dier Mardi CFO & Executive Vice President |
2022-10-17 18:49:56 | 66,695 0 |
66,695 | Form 4 |
14 | Huizenga Theodore Alan SVP, Chief Accounting Officer |
2025-03-04 20:00:32 | 55,756 0 |
55,756 | Form 4 |
15 | Bedrosian Camille L EVP and Chief Medical Officer |
2023-03-03 20:00:36 | 46,720 0 |
46,720 | Form 4 |
16 | NARACHI MICHAEL Director |
2024-06-20 14:24:21 | 36,850 0 |
36,850 | Form 4 |
17 | WELCH DANIEL G Director |
2024-06-20 14:25:14 | 36,850 0 |
36,850 | Form 4 |
18 | Dunsire Deborah Director |
2024-06-20 14:29:35 | 34,975 0 |
34,975 | Form 4 |
19 | Fust Matthew K Director |
2024-06-20 14:26:43 | 30,105 0 |
30,105 | Form 4 |
20 | SULIMAN SHEHNAAZ Director |
2024-06-20 14:22:04 | 30,100 0 |
30,100 | Form 4 |
21 | Ray Amrit Director |
2024-06-20 14:23:42 | 27,525 0 |
27,525 | Form 4 |
22 | Ekman Lars Director |
2022-06-28 13:53:43 | 23,990 0 |
23,990 | Form 4 |
23 | Dallas Jayson Donald Alexander EVP & Chief Commercial Officer |
2018-06-04 16:50:14 | 23,830 0 |
23,830 | Form 4 |
24 | Hogenhuis Wladimir Chief Operating Officer |
2019-10-07 19:40:08 | 18,703 0 |
18,703 | Form 4 |
25 | Steen Marten Director |
2014-02-03 20:30:09 | 17,500 0 |
17,500 | Form 4 |
26 | Sanders Corazon (Corsee) D. Director |
2024-07-03 14:07:33 | 12,009 0 |
12,009 | Form 4 |
27 | AGARWAL SUNIL Chief Medical Officer |
2016-08-23 17:52:15 | 9,136 0 |
9,136 | Form 4 |
28 | Nadav Eran Director |
2014-07-17 16:15:52 | 7,500 0 |
7,500 | Form 4 |
29 | SIEGALL CLAY B Director |
2020-08-11 12:21:29 | 4,146 0 |
4,146 | Form 4 |